Skip to main content
OpenTrials
Completed

NCT Number: NCT05910229

Telephone Paramedical Support Prior to the Radiotherapy Simulation Scanner for Patients with Prostate Cancer

The goal of this clinical trial is to evaluate the impact of a phone call before the simulation CT scan in management of care of patients with prostate cancer.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Radiotherapy Genital Diseases Genital Diseases, Male Genital Neoplasms, Male Male Urogenital Diseases Neoplasms Neoplasms by Site Prostate Cancer Prostatic Diseases Prostatic Neoplasms Urogenital Diseases Urogenital Neoplasms

Age range

18 year and older

Sex eligibility

Male

Study type

Interventional

Phase

Not applicable

Primary location

Hôpital du Scorff

Lorient, Brittany Region, 56100, France

About this study

After being informed about the study, all patients who have given written informed consent and who met eligibility requirement will be randomized in a simple blind manner ( investigator) in a 1:1 ration.

The main question it aims to answer is : Does a phone call before the simulation CT scan has an effectiveness on patients compliance of the recommendations and therefore on obtaining quality images.

There is no additional risk of patients involvement.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Adult
  • Patient coming for prostate cancer treatment with or without lymph node irradiation
  • Minimum of 48 hours between the onco radiotherapist and the CT scan
  • Signed a written informed consent form
  • Affiliated to the social security system

Exclusion criteria

  • Patient not understanding French
  • Patient not reachable by phone
  • Individual of full age deprived of liberty or placed under a legal protection measure

Treatment and study plan

phone call

Other

In the experimental arm the patient will be called 3 days before the CT scan

Primary outcomes

  1. Assess the value of a telephone call in terms of compliance recommendations for preparation (empty rectum and full bladder) necessary to perform the CT scanner simulation in the management of patients with prostate cancer.

    Time frame: From the day of the consultation with the radiotherapist to the day of the CT scanner, up to three month after the inclusion

    The proportion of patients for whom it is necessary to renew the CT scanner simulation.

Secondary outcomes

  1. Assess the impact of a telephone call upstream of the simulation scanner on patient preparation according to recommendations.

    Time frame: From the day of the consultation with the radiotherapist to the day of the CT scanner, up to three month after the inclusion

    The number of patients who performed the preparation for the scanner.

  2. Assess the impact of a telephone call upstream of the simulation scanner on reading the recommendation sheet given to the patient during the announcement medical consultation.

    Time frame: From the day of the consultation with the radiotherapist to the day of the CT scanner, up to three month after the inclusion

    The number of patients who read the recommendations

Sponsors and collaborators

Lead sponsor

Groupe Hospitalier de Bretagne Sud

Other

Registry information

Official study title

Interest of a Telephone Paramedical Support Prior to the Radiotherapy Simulation Scanner to Ensure the Realization of Specific Recommendations for the Management of Patients with Prostate Cancer.

Acronym: RTEPROST

Important dates

Study start
2022
Primary completion
2024
Study completion
2025
First posted
Jun 18, 2023
Registry last updated
Mar 18, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.